BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32206720)

  • 1. Alcohol dependence potentiates substance P/neurokinin-1 receptor signaling in the rat central nucleus of amygdala.
    Khom S; Steinkellner T; Hnasko TS; Roberto M
    Sci Adv; 2020 Mar; 6(12):eaaz1050. PubMed ID: 32206720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol Dependence and Withdrawal Impair Serotonergic Regulation of GABA Transmission in the Rat Central Nucleus of the Amygdala.
    Khom S; Wolfe SA; Patel RR; Kirson D; Hedges DM; Varodayan FP; Bajo M; Roberto M
    J Neurosci; 2020 Sep; 40(36):6842-6853. PubMed ID: 32769108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin action.
    Karagiannides I; Stavrakis D; Bakirtzi K; Kokkotou E; Pirtskhalava T; Nayeb-Hashemi H; Bowe C; Bugni JM; Nuño M; Lu B; Gerard NP; Leeman SE; Kirkland JL; Pothoulakis C
    Endocrinology; 2011 Jun; 152(6):2197-205. PubMed ID: 21467195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression.
    Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M
    Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
    Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
    Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol Dependence Disrupts Amygdalar L-Type Voltage-Gated Calcium Channel Mechanisms.
    Varodayan FP; de Guglielmo G; Logrip ML; George O; Roberto M
    J Neurosci; 2017 Apr; 37(17):4593-4603. PubMed ID: 28363981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
    Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
    Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat.
    Trafton JA; Abbadie C; Basbaum AI
    J Neurosci; 2001 May; 21(10):3656-64. PubMed ID: 11331395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-FOS expression in the rat brain in response to substance P and neurokinin B.
    Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
    Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors.
    Kissler JL; Walker BM
    Neuropsychopharmacology; 2016 Jan; 41(2):560-7. PubMed ID: 26105136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurokinin-1 receptor-expressing neurons that contain serotonin and gamma-aminobutyric acid in the rat rostroventromedial medulla are involved in pain processing.
    Chen T; Wang XL; Qu J; Wang W; Zhang T; Yanagawa Y; Wu SX; Li YQ
    J Pain; 2013 Aug; 14(8):778-92. PubMed ID: 23664790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.
    Lai JP; Ho WZ; Kilpatrick LE; Wang X; Tuluc F; Korchak HM; Douglas SD
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7771-6. PubMed ID: 16675550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The substance P and neurokinin-1 receptor system in human thyroid cancer: an immunohistochemical study.
    Isorna I; Esteban F; Solanellas J; Coveñas R; Muñoz M
    Eur J Histochem; 2020 Apr; 64(2):. PubMed ID: 32363847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of substance P-induced defensive behavior via neurokinin-1 receptor antagonism in the central and medial but not basolateral nuclei of the amygdala in male Wistar rats.
    Bassi GS; Carvalho MC; Almada RC; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():146-154. PubMed ID: 28390968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
    Vigna SR
    Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
    Li X; Ma G; Ma Q; Li W; Liu J; Han L; Duan W; Xu Q; Liu H; Wang Z; Sun Q; Wang F; Wu E
    Mol Cancer Res; 2013 Mar; 11(3):294-302. PubMed ID: 23345604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.
    Burmeister AR; Johnson MB; Chauhan VS; Moerdyk-Schauwecker MJ; Young AD; Cooley ID; Martinez AN; Ramesh G; Philipp MT; Marriott I
    J Neuroinflammation; 2017 Dec; 14(1):245. PubMed ID: 29237453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
    Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
    J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of neurokinin-1 receptor expression in rat spinal cord by an N-terminal metabolite of substance P.
    Velázquez RA; McCarson KE; Cai Y; Kovács KJ; Shi Q; Evensjö M; Larson AA
    Eur J Neurosci; 2002 Jul; 16(2):229-41. PubMed ID: 12169105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin (NK)-1 receptor expression in monocytes from bipolar disorder patients: a pilot study.
    Amoruso A; Bardelli C; Cattaneo CI; Fresu LG; Manzetti E; Brunelleschi S
    J Affect Disord; 2015 Jun; 178():188-92. PubMed ID: 25841180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.